CEVI.ST · PEAD ↑ 58

CellaVision reported Q2 2026 EPS of 1.37 on 2026-07-16, beating the 1.32 consensus by 0.05 (+3.8%).

Print-day reaction was a muted +0.9% versus the prior close, suggesting the initial market digest was restrained. The overnight gap to the T+1 open was a sharp +6.9%, indicating a decisive after-hours re-rating as the earnings beat was more fully absorbed. Over days 1–3 the stock gave back –1.6%, a partial fade but not a reversal of the overnight move. Cumulative abnormal return of +7.8% versus SPY.US puts this firmly in PEAD long territory; the documented drift pattern is held through 2026-10-13.